We have shown that downregulation of APE1 inhibited tumor growth and sensitized these cells to conventional chemotherapy drugs gemcitabine, 5-FU and oxaliplatin both in vitro and in a in vivo xenograft model. The gene discussed is APEX1; the disease is neoplasm.